Jasper Therapeutics, Inc.

Healthcare · Biotechnology · United States

Last price 0.532 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 17.70M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Jasper Therapeutics, Inc., a clinical stage biotechnology company, focuses on the design and development of therapies to treat immune-mediated diseases. It is advancing a pipeline of medicines, including KP-104, a dual-complement inhibitor that has demonstrated positive outcomes in paroxysmal nocturnal hemoglobinuria (PNH) and is under evaluation in other unmet need nephrology disorders; Briquilimab is an anti-KIT antibody, which has demonstrated clinical results as a conditioning agent for stem cell transplant and mast cell mediated diseases, ...